Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	88.01	3637.28	1934.58
Graham Fair Price	18.39	27572.27	23290.28
PEG	-60.80	0.07	-0.17
Price/Book	12.91	0.39	0.34
Price/Cash Flow	-29.76	5.09	7.25
Prices/Earnings	-19.47	3.40	4.22
Price/Sales	-35.92	1.18	1.84
Price/FCF	-29.76	5.09	7.25
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-70.55	1.00	3.40
Operating Margin	-70.55	1.00	3.40
ROA	38.65	< 0.005	< 0.005
ROE	0.02	0.03	40.21
ROIC	0.06	0.03	-52.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	< 0.005	160.17
Dividends QOQ	< 0.005	-1.00	68019.52
EBIT QOQ	16.61	-0.48	-97.10
EPS QOQ	-0.25	0.52	105.47
FCF QOQ	1.20	0.61	-49.50
Revenue QOQ	1.65	0.76	-53.89
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-2.42	0.00	inf
Days Sales Outstanding (DSO)	37.22	0.00	inf
Inventory Turnover	-37.24	0.00	inf
Debt/Capitalization	0.89	0.89	0.24
Quick Ratio	< 0.005	-0.02	-723.69
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	34514.97	34508.09	-0.02
Cash	-3063.46	-3480.95	-13.63
Capex	-127.91	-65.82	48.54
Free Cash Flow	1626.60	2614.22	60.72
Revenue	6410.31	11293.50	76.18
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.23	0.16	-30.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1847.38	3480.31	88.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating